T cells are supposed to be relentless. These white blood cells patrol the body, identify threats, and destroy them.

Researchers have uncovered a previously hidden “internal brake” on immune cells that limits their ability to fight cancer, ...

Tivic pivots to TLR5 immunotherapy (Entolimod/Entolasta), launches Velocity Bioworks CDMO, boosts cash—read now.

Immunotherapy has been one of the most transformative treatments for cancer patients in recent decades, shifting the emphasis ...

Patients with HER2-positive breast cancer in the FLAMINGO-01 phase 3 clinical trial are seeing a continued reduction in recurrence rates, Greenwich LifeSciences, Inc. has reported. The preliminary ...

Imaging studies of more than 27,000 adults link a healthier thymus on CT scans with a longer life and lower risks of cardiovascular disease and lung cancer. Across 3,400 cancer patients, thymic health ...

There are many different ways that doctors treat cancer, from chemotherapy to surgery. Another part of cancer treatment that ...

Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one day serve as a universal immunotherapy for cancers that form solid tumors, including ...

Developing the system required careful fine-tuning. Too much stimulation can wear out immune cells, while too little allows them to lose function. The researchers optimized the strength of activation ...

Mesothelin-targeted CAR-NKT cells leveraged three recognition mechanisms, potentially limiting antigen escape and immunoediting compared with single-pathway CAR-T constructs. Complete tumor ...

Researchers from The University of Texas MD Anderson Cancer Center have found that simultaneously blocking two key "don't eat ...

Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...